TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
ALKS

Alkermes Plc

Healthcare · Drug Manufacturers - Specialty & Generic

43.40$ -7.1% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Cash Flow

Alkermes Plc (ALKS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at 521 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow ALKS
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
11 -40 -64 19 99 72 83 102 21 401 439 521
98 86 94 99 104 80 82 79 78 75 29 27
60 97 94 84 105 101 90 88 94 101 97 99
-38 19 78 83 145 123 99 97 89
11 82 -27 -4.9 -7.4 65 13 -26 13 -37 -98 119
34 53 44 51 69 91 42 29 38 48 33 40
-263 -43 127 -18 -22 -142 -11 -66 -65 53 -111 295
0.0 0.0 0.0 0.0 9.6 0.7 8.7 1.4
-13 -26 -13 -16 -20 -9.3 -7.7 -17 -18 -28 -200 -31
-6.8 -6.8 -69 -3.0 -2.9 -2.8 -2.8 20 -3.0 -3.0 -292 0.0
309 41 -58 4.1 -1.6 6.8 -2.2 29 -1.6 -290 -494 12
57 -43 5.3 4.9 75 -63 69 65 -45 165 -166 829
-23 -93 -107 -32 30 -19 41 73 -17 353 406 480

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?